Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-27
DOI
10.1038/s41467-022-30649-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID reinfections surge during Omicron onslaught
- (2022) Smriti Mallapaty NATURE
- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
- (2022) Sandile Cele et al. NATURE
- Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
- (2022) Lihong Liu et al. NATURE
- Rapid increase in Omicron infections in England during December 2021: REACT-1 study
- (2022) Paul Elliott et al. SCIENCE
- Role of Omicron variant of SARS-CoV-2 in children in Germany
- (2022) Stefan Bittmann World Journal of Pediatrics
- Covid-19: Omicron variant is linked to steep rise in hospital admissions of very young children
- (2022) Ingrid Torjesen BMJ-British Medical Journal
- Omicron variant susceptibility to neutralizing antibodies induced in children by natural SARS-CoV-2 infection or COVID-19 vaccine
- (2022) Lin-Lei Chen et al. Emerging Microbes & Infections
- SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity
- (2022) Haolin Liu et al. Frontiers in Immunology
- Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
- (2022) Laura D. Zambrano et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- Establishment of a well-characterized SARS-CoV-2 lentiviral pseudovirus neutralization assay using 293T cells with stable expression of ACE2 and TMPRSS2
- (2021) Sabari Nath Neerukonda et al. PLoS One
- Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients
- (2021) Juanjie Tang et al. Nature Communications
- Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution
- (2021) Supriya Ravichandran et al. Science Advances
- Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
- (2021) Stacey A. Lapp et al. PLoS One
- Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2
- (2021) Amanda B. Payne et al. JAMA Network Open
- Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
- (2021) Juanjie Tang et al. iScience
- Why Parents Still Hesitate to Vaccinate Their Children Against COVID-19
- (2021) Melissa Suran JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- (2021) Salim S Abdool Karim et al. LANCET
- Local and systemic responses to SARS-CoV-2 infection in children and adults
- (2021) Masahiro Yoshida et al. NATURE
- Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection
- (2021) Alexander C. Dowell et al. NATURE IMMUNOLOGY
- SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19
- (2021) Supriya Ravichandran et al. NATURE IMMUNOLOGY
- Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
- (2021) Emmanuel B. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12–18 Years — United States, June–September 2021
- (2021) Samantha M. Olson et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
- (2020) Supriya Ravichandran et al. Science Translational Medicine
- S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
- (2020) Phuong Nguyen-Contant et al. mBio
- A flexible and nearly optimal sequential testing approach to randomized testing: QUICK‐STOP
- (2019) Julian Hecker et al. GENETIC EPIDEMIOLOGY
- Optimizing Virus Identification in Critically Ill Children Suspected of Having an Acute Severe Viral Infection*
- (2016) Adrienne G. Randolph et al. Pediatric Critical Care Medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started